Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries | CPRD

Publication Type:

Journal Article

Authors:

Heintjes, E. M.; Bezemer, I. D.; Prieto-Alhambra, D.; Smits, E.; Booth, H. P.; Dedman, D.; He, Y.; Hoti, F.; Vehkala, M.; de Vogel, S.; Robinson, N. J.; Appenteng, K.; Penning-van Beest, F. J. A.

Source:

Clin Epidemiol, Volume 12, p.423-433 (2020)